News Focus
News Focus
Followers 2
Posts 1107
Boards Moderated 0
Alias Born 11/10/2006

Re: None

Sunday, 11/16/2008 9:49:45 PM

Sunday, November 16, 2008 9:49:45 PM

Post# of 8474
Backhanded compliment from RPRX's old friends on Biotech Values

Late-Stage Products Looking for a Home


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=33601483

I don't claim to know enough to be sure about all the other products listed, but Proellex looks like the best in class by virtue of some key information omitted from the tabulation: outstanding efficacy stats, severity and prevalence of unmet need and multi-billion revenue potential at reasonable price per patient.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RPRX News